Prevalence and molecular identification of protozoan parasites in cancer patients in Jordan | Synapse
March 8, 2026Open Access
Prevalence and molecular identification of protozoan parasites in cancer patients in Jordan
Key Points
The aim is to investigate the prevalence and molecular identification of protozoan parasites in cancer patients.
Conducted prevalence assessment of protozoan parasites in cancer patients
Utilized molecular techniques for identification of parasites
Focused on a population of cancer patients in Jordan
Identified significant prevalence of protozoan infections among cancer patients
Emphasized the need for regular screening and effective management protocols
Abstract
This study highlights the significance of protozoan parasitic infections among cancer patients, emphasizing the need for screening and management to improve patient outcomes.